Follow us on:

Paul Titley – Managing Director – Formulation Development Business Unit

Professional:

Paul founded R5 Pharmaceuticals in 2006 to provide formulation development, analytical chemistry and GMP services to the global biotech and pharmaceutical industry. The company achieved a turnover of £4million and was acquired by Aesica in June 2010 to operate as Aesica’s Formulation Development division and is widely acknowledged as one of the leading providers of pharmaceutical dosage form development across Europe.

Prior to establishing R5 Pharmaceuticals and joining Aesica, Paul qualified as a chemist during his twenty-five years’ service with Wellcome where he left in 1996 as Head of Worldwide Technical Support. He also worked in business development and senior management for Quintiles and Encap Drug Delivery, before becoming an independent consultant in 2005 working with clients in India and the Czech Republic.

Qualifications:

  • Chartered Chemist (C Chem).
  • Member of the Royal Society of Chemistry.

At Aesica:

  • Paul works strategically to enhance the Formulation Development offering across the US while consolidating and building upon its achievements in Europe.
  • Paul is also a member of Aesica’s Scientific Advisory Board.